Seven Fleet Capital Management Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$318.3M
Q ending 2026-03-31
Prior quarter
$147.8M
Q ending 2025-12-31
Change
+115.4% QoQ
Positions
115
reported holdings
Largest positions
Top 100 of 115 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Cg Oncology Inc | Shares | $97.4M | 1.4M | |
| Tango Therapeutics Inc | TNGX | Shares | $10.5M | 502K |
| Revolution Medicines Inc | RVMD | Shares | $7.9M | 81K |
| Tyra Biosciences Inc | TYRA | Shares | $7.5M | 196K |
| Liquidia Corporation | LQDA | Shares | $7.1M | 188K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $7.1M | 210K |
| Century Therapeutics Inc | IPSC | Shares | $6.7M | 2.9M |
| Enliven Therapeutics Inc | ELVN | Shares | $6.4M | 164K |
| Vaxcyte Inc | PCVX | Shares | $6.3M | 108K |
| Tango Therapeutics Inc | Shares | $6.3M | 301K | |
| Cogent Biosciences Inc | COGT | Shares | $5.8M | 149K |
| Avalo Therapeutics Inc | Shares | $5.4M | 360K | |
| Minerva Neurosciences Inc | Shares | $5.4M | 889K | |
| Cg Oncology Inc | CGON | Shares | $5.1M | 76K |
| Pharvaris N V | Shares | $4.9M | 173K | |
| Abivax Sa | ABVX | Shares | $4.8M | 43K |
| Dianthus Therapeutics Inc | DNTH | Shares | $4.6M | 54K |
| Pharvaris N V | Shares | $4.1M | 144K | |
| Cytokinetics Inc | CYTK | Shares | $4.0M | 61K |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $3.9M | 116K |
| Enliven Therapeutics Inc | Shares | $3.7M | 95K | |
| Erasca Inc | ERAS | Shares | $3.6M | 222K |
| Roivant Sciences Ltd | Shares | $3.6M | 128K | |
| Cytomx Therapeutics Inc. | Shares | $3.4M | 714K | |
| Avalo Therapeutics Inc | AVTX | Shares | $3.2M | 214K |
| Century Therapeutics Inc | Shares | $3.2M | 1.4M | |
| Eupraxia Pharmaceuticals Inc | EPRX | Shares | $3.1M | 434K |
| Ideaya Biosciences Inc | IDYA | Shares | $2.9M | 86K |
| Taysha Gene Therapies Inc | TSHA | Shares | $2.8M | 626K |
| Ascendis Pharma A/S | Shares | $2.8M | 12K | |
| Compass Therapeutics Inc | CMPX | Shares | $2.7M | 517K |
| Damora Therapeutics Inc | DMRA | Shares | $2.6M | 101K |
| Kalvista Pharmaceuticals Inc | 4XC1 | Shares | $2.6M | 128K |
| Relay Therapeutics Inc | RLAY | Shares | $2.6M | 258K |
| Axsome Therapeutics Inc. | AXSM | Shares | $2.4M | 14K |
| Compass Therapeutics Inc | Shares | $2.2M | 424K | |
| Dianthus Therapeutics Inc | Shares | $2.2M | 27K | |
| Eupraxia Pharmaceuticals Inc | Shares | $2.0M | 276K | |
| Definium Therapeutics Inc | DFTX | Shares | $1.9M | 100K |
| Mineralys Therapeutics Inc | MLYS | Shares | $1.9M | 70K |
| Soleno Therapeutics Inc | Shares | $1.8M | 54K | |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $1.8M | 3K |
| Cytomx Therapeutics Inc. | CTMX | Shares | $1.7M | 371K |
| Leonabio Inc | LONA | Shares | $1.7M | 165K |
| Savara Inc | SVRA | Shares | $1.6M | 296K |
| Perspective Therapeutics Inc | CATX | Shares | $1.6M | 379K |
| Assembly Biosciences Inc | ASMB | Shares | $1.6M | 56K |
| Sab Biotherapeutics Inc | Shares | $1.5M | 400K | |
| Minerva Neurosciences Inc | NERV | Shares | $1.5M | 248K |
| Zai Lab Ltd | ZLAB | Shares | $1.5M | 78K |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $1.4M | 20K |
| Corvus Pharmaceuticals Inc | CRVS | Shares | $1.2M | 83K |
| Vaxcyte Inc | Shares | $1.2M | 20K | |
| Arrivent Biopharma Inc | AVBP | Shares | $1.2M | 50K |
| Larimar Therapeutics Inc | LRMR | Shares | $1.2M | 257K |
| Krystal Biotech Inc | KRYS | Shares | $1.1M | 4K |
| Inventiva Sa | IVA | Shares | $1.1M | 200K |
| Lipocine Inc New | LPCN | Shares | $998K | 125K |
| Spyre Therapeutics Inc | SYRE | Shares | $993K | 20K |
| Biocryst Pharmaceuticals Inc | BCRX | Shares | $976K | 102K |
| Xencor Inc | XNCR | Shares | $965K | 80K |
| Celldex Therapeutics Inc New | CLDX | Shares | $929K | 29K |
| Replimune Group Inc | REPL | Shares | $921K | 120K |
| Maze Therapeutics Inc | MAZE | Shares | $917K | 31K |
| Climb Bio Inc | CLYM | Shares | $895K | 131K |
| Compass Pathways Plc | CMPS | Shares | $874K | 158K |
| Alkermes Plc | Shares | $855K | 24K | |
| Silence Therapeutics Plc | SLN | Shares | $826K | 157K |
| Corbus Pharmaceuticals Hldgs | CRBP | Shares | $805K | 86K |
| Celcuity Inc | CELC | Shares | $685K | 6K |
| An2 Therapeutics Inc | ANTX | Shares | $683K | 200K |
| Denali Therapeutics Inc | DNLI | Shares | $677K | 35K |
| United Therapeutics Rp Del | UTHR | Shares | $669K | 1K |
| Eli Lilly & Co | LLY | Shares | $662K | 720 |
| Verastem Inc | VSTM | Shares | $654K | 123K |
| Liquidia Corporation | Shares | $642K | 17K | |
| Geron Corp | GERN | Shares | $632K | 424K |
| Opus Genetics Inc | IRD | Shares | $611K | 134K |
| Inhibikase Therapeutics Inc | IKT | Shares | $547K | 326K |
| Context Therapeutics Inc | CNTX | Shares | $500K | 191K |
| Bright Minds Biosciences Inc | DRUG | Shares | $467K | 6K |
| Voyager Therapeutics Inc | VYGR | Shares | $445K | 115K |
| Structure Therapeutics Inc | GPCR | Shares | $434K | 9K |
| Protagonist Therapeutics Inc | PTGX | Shares | $422K | 4K |
| Prothena Corp Plc | Shares | $421K | 43K | |
| Intellia Therapeutics Inc | NTLA | Shares | $404K | 32K |
| Milestone Pharmaceuticals In | MIST | Shares | $397K | 333K |
| Sab Biotherapeutics Inc | SABS | Shares | $383K | 100K |
| Palisade Bio Inc | PALI | Shares | $373K | 213K |
| Monte Rosa Therapeutics Inc | GLUE | Shares | $371K | 23K |
| Edgewise Therapeutics Inc | EWTX | Shares | $369K | 12K |
| Unicycive Therapeutics Inc | UNCY | Shares | $367K | 56K |
| Contineum Therapeutics Inc | CTNM | Shares | $353K | 27K |
| Trevi Therapeutics Inc | TRVI | Shares | $324K | 27K |
| Evolus Inc | EOLS | Shares | $321K | 78K |
| Nektar Therapeutics | NKTR | Shares | $309K | 4K |
| Fulcrum Therapeutics Inc | FULC | Shares | $292K | 38K |
| Septerna Inc | SEPN | Shares | $275K | 11K |
| Ocular Therapeutix Inc | OCUL | Shares | $265K | 31K |
| Zentalis Pharmaceuticals Inc | ZNTL | Shares | $257K | 110K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.